Hunting Cures Is Hard Enough; Rare Diseases Up The Ante

Rare diseases are challenging. Because there are fewer diagnosed cases, patients willing to share their experiences become essential to the scientists developing drugs. Pfizer’s Brenda Cooperstone rely on these patients, as their willingness to share helps people like her develop cures that could transform these peoples’ lives.

Check out the above video to learn more about the unique hurdles of solving rare diseases and watch all the episodes of Cure Hunters.

More Cure Hunters episodes:

Episode 1 | How Are Medicines Made?

Episode 2 | Harnessing The Immune System To Fight Cancer

Episode 3 | The Itch That Rashes

Episode 4 | NASH: The Silent Killer

Episode 5 | Precision Medicine: Targeting Cancer At The Source

Episode 6 | Building a Mirror Molecule

Episode 8 | Take Your Breath Away

Episode 9 | Clinical Trials: Driving The Hunt Forward

Episode 10 | A Constant Threat

Episode 11 | Engineering Health